Search
for
Sort by
Research 691–720 of 1000+
- Alopecia – New building blocks
- NF-κB in biology and targeted therapy: new insights and translational implications
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- Alopecia areata
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- New Treatment Options for Alopecia Areata
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Folliculitis decalvans responsive to tofacitinib: A case series
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE
- Alopecia universalis. Partial response to tofacitinib
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib